Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Autoimmune Diseases (Early Phase 1)
Colitis, Ulcerative (Early Phase 1)
Crohn Disease (Early Phase 1)
Dermatomyositis (Early Phase 1)
Enteropathy-Associated T-Cell Lymphoma (Phase 1)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 2)
Leukemia (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 1)
Leukemia, T-Cell (Phase 1)
Lymphoma (Phase 1/Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1)
Neoplasms (Phase 2)
Still's Disease, Adult-Onset (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue